Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|October 16, 2025
Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic TargetMichele Correale, Valentina Mercurio, Ester Maria Lucia Bevere, et al.
ESC Heart Failure|June 15, 2022
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEFValeria Visco, Ilaria Radano, Alfonso Campanile, et al.
Pharmacological Research|March 30, 2021
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic developmentVincenzo Lionetti, Sveva Bollini, Raffaele Coppini, et al.
Circulation. Cardiovascular Imaging|October 17, 2023
Impaired Cardiac and Skeletal Muscle Energetics Following Anthracycline Therapy for Breast CancerDavid T Gamble, James Ross, Hilal Khan, et al.
European Journal of Heart Failure|July 18, 2025
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-OncologyAmina Rakisheva, Dimitrios Farmakis, Andrea Attanasio, et al.
European Journal of Preventive Cardiology|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.
European Journal of Heart Failure|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.
Cardiovascular Diabetology|November 23, 2024
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is betterFrancesco Loria, Pasquale Mone, Antonella Rispoli, et al.
European Journal of Heart Failure|September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-OncologyKalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
International Journal of Cardiology|January 9, 2022
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic studyErberto Carluccio, Frank L Dini, Roberto Bitto, et al.
Pageof 10